Studies were selected based on their relevance to the interactions between GLP-1 receptor agonists and the gut microbiota, with particular attention to mechanisms potentially influencing treatment response and metabolic outcomes
The problem is systemic, not local
PlexusDx's Precision Peptide Genetic Test ($99 add-on after first month) analyzes 14 peptide pathways including your GLP1R, GIPR, FTO, and MC4R variants, predicting whether you'll be a fast responder (results by week 2-3) or slower responder (results by week 4-6)
During this stage, your medical history and weight loss goals are evaluated virtually, ensuring a personalized tirzepatide treatment plan tailored to your needs
Literature on endobariatric modalities in MASLD is growing but not explicitly addressed in current societal guidelines [Table 5] [98-102]
At the highest dose, people lost an average of 28% of their body weight when they took retatrutide and stayed on it as prescribed in the trial